DongSung Pharmaceutical Rises 5.2% Amid COVID-19 (Dexamethasone) Theme Uptrend

On the 21st, the COVID-19 (Dexamethasone) theme rose by 3.07% compared to the previous day, showing strength, while Dongsung Pharmaceutical, which is attracting attention as a related stock, surged by 5.2% compared to the previous day. Dongsung Pharmaceutical is known as a manufacturer of pharmaceuticals and cosmetics such as the hair dye Seven Eight and Jeongrohwan.

[Graph] Major stock price changes in the COVID-19 (Dexamethasone) theme

According to provisional data compiled at 11:55, foreigners are net selling 10,000 shares of Dongsung Pharmaceutical.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Dongsung Pharmaceutical’s quant financial score is 9.69 points, which is lower in stability, profitability, and growth scores compared to the average of other stocks related to COVID-19 (Dexamethasone). This can be interpreted as Dongsung Pharmaceutical having relatively low investment attractiveness compared to other stocks from a financial perspective. On the other hand, Hwanin Pharmaceutical ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of analysis by the Robo Algorithm based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.